2 enrolling by invitation. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial Colchicine 0.5 MG oral tablet twice daily, Placebo Oral Tablet - Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) | Phase 2 / Phase 3 | Enrolling by invitation | National Taiwan University Hospital | 400 | 2026-07-06 | 2026-07-10 |
| A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa Sonelokimab - Hidradenitis Suppurativa | Phase 3 | Enrolling by invitation | MoonLake Immunotherapeutics AG | 835 | 2025-06-27 | 2026-06-08 |
Hidradenitis (1) · Hidradenitis Suppurativa (1) · Skin Diseases (1) · Skin Diseases, Bacterial (1) · Suppuration (1) · Sweat Gland Diseases (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Infections (1) · Skin Diseases, Infectious (1) · Skin and Connective Tissue Diseases (1)
Colchicine (1) · sonelokimab (1)
MoonLake Immunotherapeutics AG (1) · National Taiwan University Hospital (1)
Belgium (1) · Bulgaria (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Portugal (1) · Slovakia (1) · Spain (1) · Taiwan (1)